Based on the SPECT and PET results as well as the postmortem findings described above, mAChRs and nAChRs (i.e., α7/β2-nAChRs, and M1/M4-mAChRs) are emerging as targets for developing novel treatments for psychotic disorders. The gene discussed is CHRNA4; the disease is psychotic disorder.